Investing.com - Hims Hers Health (NYSE: HIMS) reported first quarter EPS of $-0.05, $0.03 worse than the analyst estimate of $-0.02. Revenue for the quarter came in at $190.78M...
By Davit KirakosyanInvesting.com -- Here is your daily Pro Recap of the biggest earnings headlines you may have missed on InvestingPro since yesterday’s close. Start your...
Last year was a remarkable period for companies to go public via special purpose acquisition companies (SPACs). In 2020, in fact, there were 248 completed deals in the US. In 2019,...
Hims & Hers Health, Inc. is a consumer-first platform focused on providing personalized health and wellness experiences to consumers. The Company's digital platform enables access to treatments for a range of conditions, including those related to sexual health, hair loss, dermatology, mental health and primary care. It connects patients to licensed healthcare professionals who can prescribe medications when appropriate. The prescriptions are fulfilled online through licensed pharmacies on a subscription basis. Through the Hims & Hers mobile applications, consumers can access a range of educational programs, wellness content, community support, and other services that promote lifelong health and wellness. The Company's products include shampoo, conditioner, biotin gummies, anti-aging cream, vitamin c serum, acne cream and moisturizer. Its products are sold in tens of thousands of retail locations in the United States.
|Average||12.82 (+43.88% Upside)|
|No. of Analysts||11|
|Moving Averages||Buy||Buy||Neutral||Strong Sell||Buy|
|Technical Indicators||Strong Buy||Strong Buy||Strong Buy||Strong Sell||Strong Buy|
|Summary||Strong Buy||Strong Buy||Buy||Strong Sell||Strong Buy|